Inflammaging and the Skin

J Invest Dermatol. 2021 Apr;141(4S):1087-1095. doi: 10.1016/j.jid.2020.11.006. Epub 2021 Jan 7.

Abstract

As global life expectancy continues to rise, we are challenged with maintaining health into old age. One strategy is to target the chronic low-level inflammation associated with aging, termed inflammaging. This is characterized by increased levels of circulating proinflammatory cytokines and a shift toward cellular senescence, changes that are believed to drive many age-associated conditions, including dementia, arthritis, and type 2 diabetes. As with other organs, the skin undergoes functional decline during aging, becoming more fragile and susceptible to infection; however, the contribution of inflammaging is not well-understood. This review article describes the evidence for inflammaging in the skin, its relationship with senescence, and how this relates to declining skin structure and function.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cellular Senescence / immunology
  • Cytokines / metabolism
  • Fibroblasts / immunology
  • Fibroblasts / metabolism
  • Fibroblasts / pathology
  • Healthy Aging / immunology*
  • Humans
  • Immunosenescence*
  • Inflammation / immunology*
  • Keratinocytes / immunology
  • Keratinocytes / metabolism
  • Keratinocytes / pathology
  • Langerhans Cells / immunology
  • Langerhans Cells / metabolism
  • Langerhans Cells / pathology
  • Skin / cytology
  • Skin / immunology
  • Skin / metabolism
  • Skin / pathology*
  • Skin Aging / immunology*
  • Skin Aging / pathology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • T-Lymphocytes / pathology

Substances

  • Cytokines